In the diabetes TRIUMPH-2 trial, reported side effects included: Diarrhea (around 27 to 34 percent of participants, depending on the dose) Nausea (14 to 28 percent) Constipation (14 to 17 percent) Decreased appetite (6 to 17 percent) Vomiting (6 to 16 percent) In the TRIUMPH-3 trial for adults with severe obesity and heart disease, participants reported: Diarrhea (around 24 to 30 percent of participants, depending on the dose) Nausea (22 percent) Constipation (16 to 18 percent) Decreased appetite (14 to 15 percent) Hyperglycemia, or high blood sugar (3 to 4 percent) The high rates of diarrhea surprised Ali
Weight management and cardiovascular health are deeply connected
10.1186/s13098-022-00924-8 Summary Keywords GLP-1 receptor agonists, DPP-4 inhibitors, FAERS, adverse events, biliary disorders, pharmacovigilance Citation He L, Li J, Cheng X, Luo L and Huang Y (2025) Association between GLP-1 RAs and DPP-4 inhibitors with biliary disorders: pharmacovigilance analysis
Cinnamon may work by enhancing insulin activity, which in turn, improves blood sugar control
Many patients begin to see results within a few weeks, with significant changes typically developing over months when combined with diet and lifestyle changes
Advanced Formulas